HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Field, S. L. Articles by Hogg, P. J. Search for Related Content PubMed PubMed Citation Articles by Field, S. L. Articles by Hogg, P. J.

Lupus Antibody Bivalency Is Required to Enhance Prothrombin Binding to Phospholipid¹

Susan L. Field^*, Colin N. Chesterman^*,, Yan-Ping Dai^* and Philip J. Hogg^2,*

^* Centre for Thrombosis and Vascular Research, School of Pathology, University of New South Wales, Sidney, Australia; and Department of Haematology, South Eastern Laboratory Services, Sydney, and Division of Immunology and Cell Biology, John Curtin School of Medical Research, Australian National University, Canberra, Australia

Lupus anticoagulants (LA) are a family of autoantibodies that are associated with in vitro anticoagulant activity but a strong predisposition to in vivo thrombosis. They are directed against plasma phospholipid-binding proteins including prothrombin. We have proposed that LA propagates coagulation in flowing blood by facilitating prothrombin interaction with the damaged blood vessel wall. A murine monoclonal anti-prothrombin Ab and three of three LA IgGs enhanced prothrombin binding to 75:25 phosphatidyl choline:phosphatidyl serine vesicles measured by either ultracentrifugation or right-angle light scattering. The assembly of prothrombin and LA IgG on phospholipid vesicles was estimated by surface plasmon resonance. The on rates for prothrombin and LA IgG were approximately the same as the on rate for prothrombin alone. In contrast, the off rates for prothrombin and LA IgG were 2- to 3-fold slower than the off rate for prothrombin. LA IgG bivalency was required for enhanced prothrombin binding to phospholipid vesicles, as Fab of the LA IgGs did not influence prothrombin binding at concentrations up to 40 µM. Modeling of the interactions of prothrombin, LA IgG and phospholipid vesicles indicated that augmentation of prothrombin binding to phospholipid vesicles by LA IgG could be accounted for by the bivalency of the LA IgG and the elevated microenvironmental concentration of prothrombin on the surface of phospholipid vesicles.

This article has been cited by other articles:

				H. Gorki, V. Malinovski, and R. D.L. Stanbridge The antiphospholipid syndrome and heart valve surgery Eur. J. Cardiothorac. Surg., February 1, 2008; 33(2): 168 - 181. [Abstract] [Full Text] [PDF]

				T. Horita, K. Ichikawa, H. Kataoka, S. Yasuda, T. Atsumi, and T. Koike Human monoclonal antibodies against the complex of phosphatidylserine and prothrombin from patients with the antiphospholipid antibodies Lupus, July 1, 2007; 16(7): 509 - 516. [Abstract] [PDF]

				P. D'Agnillo, J. S. Levine, R. Subang, and J. Rauch Prothrombin Binds to the Surface of Apoptotic, But Not Viable, Cells and Serves as a Target of Lupus Anticoagulant Autoantibodies J. Immunol., March 15, 2003; 170(6): 3408 - 3422. [Abstract] [Full Text] [PDF]

				M. Jankowski, I. Vreys, C. Wittevrongel, D. Boon, J. Vermylen, Marc. F. Hoylaerts, and J. Arnout Thrombogenicity of beta 2-glycoprotein I-dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster Blood, January 1, 2003; 101(1): 157 - 162. [Abstract] [Full Text] [PDF]